Skip to content
Screener

NeoGenomics NEO Free cash flow

Free cash flow at other companies

Labcorp Holdings logo
Labcorp HoldingsLH
$313.9M-42.2%
Quest Diagnostics logo
Quest DiagnosticsDGX
$459M+5.3%
Biodesix, Inc. logo
Biodesix, Inc.BDSX
-$1.76M+73.4%
Personalis, Inc. logo
Personalis, Inc.PSNL
-$25.67M-25.4%
Guardant Health logo
Guardant HealthGH
-$71.2M-6.0%
Natera, Inc. logo
Natera, Inc.NTRA
$18.03M-20.3%

Other financials

Income statement

See full
Revenue$201.7M+11.2%
Gross profit$91.9M+18.9%
Operating income-$9.8M+79.5%
Net income$2.2M+105%
EPS (diluted)$0.02+106%

Balance sheet

See full
Cash & equivalents$145.5M-5.9%
Total debt$448.4M+534%
Total equity$785.7M-8.0%
Total assets$1.4B-3.0%

Cash flow

See full
Operating cash flow$20.0M-1.8%
CapEx$8.2M+30.0%

Valuation

See full
Market cap$2B+182%
Enterprise value$2.3B+268%
P/S2.6×+1.6×

Profitability

See full
Gross margin43.9%0.0pp
Operating margin-8.9%-2.8pp
Net margin-6.8%-2.4pp
FCF margin-4.9%

Returns & leverage

See full
Return on equity-6.3%-2.0pp
Debt / equity0.6×+0.5×
Current ratio3.6×-0.3×

Where this comes from

Calculated from NeoGenomics’s reported figures.

The source filing: NeoGenomics’s 10-Q, filed April 28, 2026. Open the filing →

Filed
Apr 28, 2026, 5:01 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001077183-26-000023

FAQ

What is NeoGenomics's free cash flow?
NeoGenomics (NEO) reported free cash flow of -$13.14M in Q1 2026.
How has NeoGenomics's free cash flow changed year-over-year?
NeoGenomics's free cash flow increased by 56.0% year-over-year, from -$29.83M to -$13.14M.
What is the long-term trend for NeoGenomics's free cash flow?
Over 2 years (2021 to 2024), NeoGenomics's free cash flow has grown at a -38.1% compound annual growth rate (CAGR), from -$90.87M to -$34.85M.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.

Ask your AI about NeoGenomics's free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude